Luts & Greenleigh Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Buy
+557
New +$191K 0.15% 104
2024
Q4
Sell
-671
Closed -$216K 79
2024
Q3
$216K Buy
671
+10
+2% +$3.27K 0.21% 78
2024
Q2
$207K Buy
+661
New +$194K 0.21% 76

Other funds holding AMGN

Luts & Greenleigh Group's AMGN Position: Q2 2026 in Review

Luts & Greenleigh Group opened a new position in Amgen (AMGN) in Q2 2026: 557 shares worth $202K. The stake represents 0.15% of the portfolio and ranks #104 among its holdings. This is a return to the name: Luts & Greenleigh Group previously reported a position in AMGN as recently as Q3 2024.

Luts & Greenleigh Group first reported a position in AMGN in Q2 2024 and has held it in 3 quarters since. The position peaked at $216K in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Luts & Greenleigh Group held 557 shares of Amgen worth $202K as of Q2 2026.
  • Amgen was a new Luts & Greenleigh Group position in Q2 2026.
  • Amgen made up 0.15% of Luts & Greenleigh Group's portfolio in Q2 2026, its #104 holding.
  • Luts & Greenleigh Group first reported a position in Amgen in Q2 2024 and has held it in 3 quarters since.
  • Luts & Greenleigh Group's Amgen position peaked at $216K in Q3 2024.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Luts & Greenleigh Group's 13F filing for Q2 2026, filed 7 Aug 2026.